NEWS


NI company launches new ‘best in class’ hand sanitiser


NPA IN FOCUS


Anne McAllister Northern Ireland Representation Manager


The Npa’s annual ask your pharmacist Week is rapidly approaching again. The campaign, which raises awareness of the value of community pharmacy and pharmacy services, takes place from 2 to 9 November.


This year’s theme is community pharmacy’s position within the local healthcare team, working alongside gps and others to provide patient-centred care. as usual, it will aim both to raise awareness of pharmacy services and to prompt conversations with key stakeholders at a local level about community pharmacy’s role and benefits.


Torax Biosciences has launched a revolutionary new, clinically-approved hand sanitiser proven to kill 99.99 per cent of bacteria and viruses.


ToraSan is formulated and developed by scientists to meet internationally- recognised quality standards. products are manufactured under strict laboratory conditions at the company’s headquarters in Northern Ireland, led by Managing Director, Dr Lawrence Mcgrath phD, MSc, TD.


ToraSan’s unique formula provides a minimum concentration of 75 per cent isopropyl, certified by the World Health Organisation to provide the optimum level of protection against bacteria and viruses. Many hand sanitisers only provide between 60-70 per cent alcohol concentration, which can be incapable of killing viruses.


‘ToraSan products are manufactured to the World Health Organisation’s recommended formulation and are independently tested and verified to ensure the integrity of antibacterial and antiviral properties,’ explains Dr Mcgrath. ‘ToraSan is formulated using isopropyl, which is the gold standard in antibacterial and antiviral defence. Not only does isopropyl provide optimal protection but it’s also kinder to skin. ethanol-based sanitisers, whilst being potentially less effective, can also cause dry and cracked skin, or lead to more severe skin conditions with prolonged use. ToraSan also contains tea tree oil, which helps protect the skin, providing its own well-known anti- inflammatory, antiseptic and antibacterial qualities.


In a major move for the company, leading medical supply distributor HDM Marketing, based in Tobermore, recently signed a new deal with Torax Biosciences to supply ToraSan hand sanitiser to 300 pharmacies across the island of Ireland.


‘Since the beginning of the pandemic, consumer awareness of hand sanitisers has not only increased, but we are seeing a switch now to more educated consumers actively researching products to ensure they are buying the best, most effective formulations on the market,’ added Harry Dunlop, Director of HDM Marketing. ’Safety is at the forefront of everyone’s minds and, for us, ToraSan is leading the way in providing that reassurance we all need as the pandemic continues into the autumn and winter months.’


Not only does ToraSan offer the highest levels of protection on the market, but the light-weight mist formula ensures quick drying on the hands without any residual stickiness and its fresh aroma and slick design make this a first-class product. No other hand sanitiser compares. ToraSan is available as an Instant Hand Sanitiser Spray in a range of volumes, from 50ml handbag bottles to 500ml desk bottles. In addition, ToraSan is available in 5-litre quantities as a liquid or adapted gel for commercial use.


If you are interested in becoming a distributor or stockist, please contact Neil gillies at neil@torasan.co.uk or on +44 7919 493 797.


For more information visit www.torasan.co.uk.


pHaRMaCy IN FOCuS - 31


Campaign materials will be available to download from the Npa website or pharmacies can order bespoke materials from the Npa.


In preparation, we are collecting case studies of integrated care in which pharmacies demonstrate great teamwork within the healthcare system. please email press@npa.co.uk to share your stories.


The Npa welcomed the announcement that HSCB, in agreement with CpNI, has launched the Community pharmacy Seasonal Influenza vaccination Service for frontline health and social care workers. This service is available from community pharmacies providing a private flu vaccination service in 2020/21 and which meet the necessary training and contract requirements. It is anticipated the service will run until 31 March 2021.


The flu vaccine is recommended for all frontline health and social care workers in Northern Ireland, including trust and non-trust employed staff. COvID-19 has reminded us all about the importance of safeguarding the wellbeing of frontline staff.


To date, vaccine uptake monitoring has only been published for frontline workers who are employed by health and social care trust organisations. The 2019/20 end of season uptake for healthcare workers was 41.2 per cent - below the target of 50 per cent.


The vaccine uptake in SCWs was just 22.8 per cent. In light of the COvID-19 pandemic, the target for 2020/21 for all health and social care staff in Northern Ireland is 75 per cent.


all support available for delivery of this service, and private flu services, will be available to our members from the Npa’s pharmacy Services and Learning and Development teams.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48